Javascript must be enabled to continue!
The regulatory role of Sirtuin 6 in coronary endothelial dysfunction in HFpEF
View through CrossRef
Sirtuin 6 (Sirt6) has been implicated in obesity, insulin resistance, type 2 diabetes mellitus, and cardiovascular diseases. Sirt6 protects EC from premature senescence, oxidative stress, and atherosclerosis by sustaining high eNOS levels and preserving cell replication. A recent publication showed that overexpressed Sirt 6 in EC mitigated heart failure with preserved ejection fraction (HFpEF) in diabetes. We hypothesize Sirt 6 regulates coronary microvascular dysfunction (CMD) in HFpEF associated with diabetic cardiomyopathy. CMD is characterized by impaired endothelial-dependent vasodilation, but detailed mechanisms have yet to be elucidated. How Sirt6 regulates coronary microvascular function remains to be determined. Inducible Sirt6 endothelial-specific knockout and wild-type (WT) mice were fed a chow or high fat and sugar (HFHS) diet. Coronary arterioles were isolated, and endothelial-dependent vasodilation (EDD) was assessed using myography (DMT). Echocardiography and treadmill exercise exertion tests were performed to evaluate cardiac function. Myocardial blood flow (MBF) was measured by doppler. Cardiac fibrosis was detected using trichrome staining, and molecular pathways were elucidated via gene and protein analysis. Our preliminary data show that the EDD of coronary arterioles of Sirt6 endothelial-specific knockout treated with HFHS was impaired, and the mediator of coronary vasodilation switched from NO to H2O2 in the Sirt6 knockout mice. Compared to the WT mice, myocardial blood flow and cardiac function were changed in Sirt6 knockout mice. Our data suggest that Sirt6 regulated coronary microvascular function through endothelial cells, and ablation of Sirt6 in endothelial cells caused CMD and diastolic dysfunction, eventually HFpEF. Further genetic profiling will elucidate the pathways and mechanisms converging with Sirt6 to regulate microvascular function in HFpEF. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.
Title: The regulatory role of Sirtuin 6 in coronary endothelial dysfunction in HFpEF
Description:
Sirtuin 6 (Sirt6) has been implicated in obesity, insulin resistance, type 2 diabetes mellitus, and cardiovascular diseases.
Sirt6 protects EC from premature senescence, oxidative stress, and atherosclerosis by sustaining high eNOS levels and preserving cell replication.
A recent publication showed that overexpressed Sirt 6 in EC mitigated heart failure with preserved ejection fraction (HFpEF) in diabetes.
We hypothesize Sirt 6 regulates coronary microvascular dysfunction (CMD) in HFpEF associated with diabetic cardiomyopathy.
CMD is characterized by impaired endothelial-dependent vasodilation, but detailed mechanisms have yet to be elucidated.
How Sirt6 regulates coronary microvascular function remains to be determined.
Inducible Sirt6 endothelial-specific knockout and wild-type (WT) mice were fed a chow or high fat and sugar (HFHS) diet.
Coronary arterioles were isolated, and endothelial-dependent vasodilation (EDD) was assessed using myography (DMT).
Echocardiography and treadmill exercise exertion tests were performed to evaluate cardiac function.
Myocardial blood flow (MBF) was measured by doppler.
Cardiac fibrosis was detected using trichrome staining, and molecular pathways were elucidated via gene and protein analysis.
Our preliminary data show that the EDD of coronary arterioles of Sirt6 endothelial-specific knockout treated with HFHS was impaired, and the mediator of coronary vasodilation switched from NO to H2O2 in the Sirt6 knockout mice.
Compared to the WT mice, myocardial blood flow and cardiac function were changed in Sirt6 knockout mice.
Our data suggest that Sirt6 regulated coronary microvascular function through endothelial cells, and ablation of Sirt6 in endothelial cells caused CMD and diastolic dysfunction, eventually HFpEF.
Further genetic profiling will elucidate the pathways and mechanisms converging with Sirt6 to regulate microvascular function in HFpEF.
This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format.
There are no additional versions or additional content available for this abstract.
Physiology was not involved in the peer review process.
Related Results
Sirtuin gene isoforms and genomic sequences of mouse and humans: Divergence across species
Sirtuin gene isoforms and genomic sequences of mouse and humans: Divergence across species
AbstractBackgroundThere are seven sirtuin genes in the mammalian genome. Each sirtuin gene contains multiple exons, and is likely to undergo alternative splicing, thereby increasin...
Abstract 1682: Radiation-induced autophagy is dependent on Sirtuin 3.
Abstract 1682: Radiation-induced autophagy is dependent on Sirtuin 3.
Abstract
Sirtuin family members (Sirtuin 1 to 7) are highly conserved proteins, both structurally and functionally, and have either NAD+ dependent enzymatic activity...
Clinical and treatment perspectives for heart failure with preserved ejection fraction
Clinical and treatment perspectives for heart failure with preserved ejection fraction
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Heart failure with preserved ejection fraction (HFpEF) currently represents half of the ~6 million heart fail...
Left Atrioventricular Coupling Index in Heart Failure Patients Using Echocardiography: A Simple Yet Effective Metric
Left Atrioventricular Coupling Index in Heart Failure Patients Using Echocardiography: A Simple Yet Effective Metric
Abstract
Background
Heart failure (HF) is a global health challenge, with significant rates of hospitalization and mortality. T...
Evidence of microvascular dysfunction in heart failure with preserved ejection fraction
Evidence of microvascular dysfunction in heart failure with preserved ejection fraction
Objective
While vascular dysfunction is well defined in patients with heart failure (HF) with reduced ejection fraction (HFrEF), disease-related alterations in th...
Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
BackgroundHeart failure with preserved ejection fraction (HFpEF) is an increasing public health concern. Currently, data regarding the clinical application value of plasma Galectin...
Clinical outcomes of patients with heart failure and preserved ejection fraction in Chinese
Clinical outcomes of patients with heart failure and preserved ejection fraction in Chinese
Background
Although heart failure is recognised as a major health problem, little is known about heart failure with preserved ejection fraction (HFPEF) in the Chi...
Characterizing obesity-HFpEF in younger acute respiratory failure patients
Characterizing obesity-HFpEF in younger acute respiratory failure patients
AbstractBackgroundHypoxic hypercapnic respiratory failure is a major cause of acute hospitalization. Cardiopulmonary insults can lead to respiratory distress and, if untreated, res...

